RVNC—ASPEN-OLS open-label safety study in CD is fully enrolled with 354 patients (reduced from original goal due to COVID). Data from ASPEN-OLS will be reported in 2021. Source: Today’s CC.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.